Bessemer Group’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.45M Buy
57,909
+19,800
+52% +$1.55M 0.01% 522
2025
Q4
$3.01M Buy
38,109
+37,928
+20,955% +$3.28M ﹤0.01% 710
2025
Q3
$17K Buy
181
+55
+44% +$4.49K ﹤0.01% 1749
2025
Q2
$8K Buy
126
+116
+1,160% +$7.55K ﹤0.01% 1878
2025
Q1
$1K Sell
10
-81
-89% -$4.84K ﹤0.01% 2302
2024
Q4
$5K Hold
91
﹤0.01% 1982
2024
Q3
$6K Buy
91
+24
+36% +$1.46K ﹤0.01% 1825
2024
Q2
$4K Hold
67
﹤0.01% 1728
2024
Q1
$5K Buy
+67
New +$4.04K ﹤0.01% 1690
2020
Q3
Sell
-26,700
Closed -$863K 1348
2020
Q2
$863K Hold
26,700
﹤0.01% 843
2020
Q1
$1.09M Buy
26,700
+4,400
+20% +$234K ﹤0.01% 589
2019
Q4
$1.38M Sell
22,300
-1,500
-6% -$99.4K ﹤0.01% 675
2019
Q3
$1.74M Buy
23,800
+800
+3% +$59.9K 0.01% 553
2019
Q2
$1.89M Buy
23,000
+2,354
+11% +$167K 0.01% 550
2019
Q1
$1.46M Buy
20,646
+3,446
+20% +$203K 0.01% 546
2018
Q4
$774K Buy
17,200
+14,764
+606% +$774K ﹤0.01% 639
2018
Q3
$138K Buy
+2,436
New +$149K ﹤0.01% 1057

Other funds holding ANIP